Sunday, April 27th, 2025

Technical Buy Opportunity: China Coal Energy Co Ltd Poised for Growth

Date of Report: October 14, 2024
Broker: CGS-CIMB Research

Company Overview

China Coal Energy Co Ltd (Stock Code: 1898) operates in the coal mining and energy sector. The company is positioned as a technical buy, with promising growth potential based on current market trends and technical indicators.

Technical Analysis Summary

China Coal Energy Co Ltd is recommended as a buy based on several technical signals. The report highlights the following key aspects:

  1. Entry Price Recommendations:

    • The following entry prices are recommended for investors looking to capitalize on the stock’s potential:
      • 10.08
      • 9.08
      • 8.40
  2. Stop Loss Level:

    • A stop loss is advised at 7.50 to mitigate downside risk and protect against significant losses.
  3. Target Prices:

    • The stock is projected to reach the following target prices:
      • Target 1: 10.50
      • Target 2: 12.80
      • Target 3: 15.20
      • Target 4: 18.00

Conclusion

China Coal Energy Co Ltd is well-positioned for growth with several target levels providing attractive upside potential. Investors are advised to enter at the recommended price points, with a solid stop loss to manage risk effectively.

Magma Group: Breaking Out of a 10-Month Consolidation with Strong Upside Potential

Date of Report: October 1, 2024Broker: CGS-CIMB Securities Malaysia Sdn. Bhd. Company Overview Magma Group Berhad is an investment holding company primarily focused on the hospitality sector. The company offers a range of services,...

OUE REIT: Buy Rating Maintained Despite Weaker Hospitality Performance – April 2025 Update

OCBC Investment Research Private Limited 25 April 2025 OUE REIT: A Tale of Two Cities – Commercial Strength Offsets Hospitality Weakness Executive Summary OUE REIT’s 1Q25 results reveal a mixed performance, with revenue and...

Sino Biopharmaceutical, Shanghai Pharmaceuticals, CSPC Pharmaceutical, WuXi AppTec, WuXi Biologics, Shanghai Pharmaceuticals

Sino Biopharmaceutical, Shanghai Pharmaceuticals, CSPC Pharmaceutical, WuXi AppTec, WuXi Biologics, Shanghai Pharmaceuticals 🏢 Sino Biopharmaceutical (1177 HK) – Leading the Charge with Innovative Drug Development Recommendation: BUY Target Price: Not specified Stop Loss: Not...